app

Blood May Link Doctor to Lawyer's Death; Overlapping Surgeries Suit; PBMs Sued

— A weekly roundup of healthcare's encounters with the courts

MedpageToday
Legal Break over a blindfolded Lady Justice statue holding scales.

Investigators said they have blood, video, and other evidence to the presumed death of a lawyer. (ABC News)

Whistleblowers have accused Tennessee-based Erlanger Health System of , saying they allowed overlapping surgeries and let trainees operate on patients without doctors' supervision. (Chattanooga Times Free Press)

Ohio attorney general Dave Yost has against pharmacy benefit managers (PBMs) Express Scripts and Prime Therapeutics, accusing them of price fixing.

Missouri physician Jonathan Philippe, MD, was sentenced to after being convicted for sexually abusing a 13-year-old girl. (KCTV)

A nurse has been charged with involuntary manslaughter in the death of a patient at an adult detention center in Virginia, .

Three women are claiming in a civil suit that a former Oklahoma University medical technician while performing EKGs. (Oklahoma News 4)

A second doctor in New York faces related to the opioid overdose death of a patient. Primary care physician Sudipt Deshmukh, MD, allegedly overprescribed controlled substances to the patient whom he knew struggled with addiction. (Rochester Beacon)

Iowa physician Scott James Piper, MD, has been , following a civil case brought by a former patient who alleged Piper had sex with her while she was receiving mental health services from him and was emotionally dependent upon him. (The Gazette)

Samer Ilayan, MD, is for discrimination, alleging he was fired for adhering to prayer times and for speaking out against colleagues who he thought were overprescribing opioids. (Detroit News)

A doctor and a chiropractor were convicted for their roles in a scheme to bill Medicaid for millions of dollars worth of unnecessary urine tests, .

The U.S. Supreme Court is mulling whether to allow Amgen to on its cholesterol-lowering drug evolocumab (Repatha), as Sanofi, which makes competitor alirocumab (Praluent), urged the court not to prevent competition on therapies that address the common health risks of heart disease and stroke. (Reuters)

  • author['full_name']

    Kristina Fiore leads MedPage’s enterprise & investigative reporting team. She’s been a medical journalist for more than a decade and her work has been recognized by Barlett & Steele, AHCJ, SABEW, and others. Send story tips to k.fiore@medpagetoday.com.